Ligand validation:4BRB

78N: (2R)-2,3-DIHYDROXYPROPYL(7Z)-PENTADEC-7-ENOATE

78N is a Ligand Of Interest in 4BRB designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4BRB_78N_A_1122	16%	92%	0.314	0.883	0.23	0.3	-	-	2	0	100%	1
4BRB_78N_A_1121	13%	88%	0.301	0.844	0.27	0.4	-	-	0	0	100%	1
4BRB_78N_A_1124	9%	91%	0.324	0.814	0.21	0.37	-	-	2	0	100%	1
4BRB_78N_B_1122	7%	94%	0.341	0.805	0.25	0.21	-	-	6	0	100%	1
4BRB_78N_D_1125	6%	89%	0.301	0.742	0.21	0.42	-	-	0	0	100%	1
4BRB_78N_A_1125	3%	88%	0.311	0.665	0.25	0.41	-	-	1	0	100%	1
4BRB_78N_A_1123	3%	88%	0.409	0.756	0.21	0.46	-	-	2	0	100%	1
4BRB_78N_D_1126	3%	78%	0.373	0.717	0.29	0.6	-	1	2	0	100%	1
4BRB_78N_B_1123	2%	90%	0.314	0.619	0.25	0.34	-	-	4	0	100%	1
4BRB_78N_C_1122	1%	90%	0.596	0.707	0.22	0.37	-	-	0	0	100%	1
5DWK_78N_B_202	26%	54%	0.223	0.864	0.85	0.92	2	1	0	0	100%	1
4D2E_78N_B_1123	25%	50%	0.208	0.844	0.98	0.97	1	2	5	0	100%	1
3ZE3_78N_A_1122	19%	48%	0.238	0.834	0.9	1.11	1	2	3	0	100%	1
5OXQ_78N_A_524	53%	46%	0.154	0.916	0.89	1.17	1	2	3	0	100%	1
6GHJ_78N_A_519	51%	46%	0.142	0.897	0.98	1.12	1	2	1	0	100%	1
6EIA_78N_A_522	35%	49%	0.216	0.904	0.95	1.03	1	1	1	0	100%	1
5OXN_78N_A_508	32%	49%	0.255	0.933	0.93	1.03	1	1	0	0	100%	1
4D2B_78N_A_1481	32%	48%	0.175	0.85	0.91	1.08	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.